Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Considering Manufacturer Contracting Guidance

Executive Summary

Document could provide more detail on the agency’s contractor management expectations, which now are covered in several different documents.


Related Content

FDA May Require Drug Importers To Verify Product Quality
Generic Facility Fee Unlikely To Be Charged Until A Few Months After GDUFA Implementation
Drug Shortages: Can The Blame Game Help Find Solutions?
FDA Envisions Many Regulatory Coalitions Dealing With Globalization Issues





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts